Alzheimer’s Drug PRI-002 Receives EMA Approval for Phase II Trial
"After decades of setbacks in drug development, there have been some recent positive developments. We can't wait to start the study," explains Prof. Dieter Willbold, co-founder of Priavoid GmbH and Director at the Jülich Institute of Structural Biochemistry, as well as a Professor of Physical Biology at HHU.
The goal of the study is to demonstrate the efficacy of PRI-002 in patients at an early stage of Alzheimer's disease. For this purpose, the drug candidate will be tested in a placebo-controlled Phase II study involving 270 patients in initially six European countries. The safety of PRI-002 for healthy volunteers and patients has already been successfully demonstrated in three Phase I studies conducted in recent years.
The Phase II study, named PRImus-AD, is sponsored by the company PRInnovation in close collaboration with Priavoid and is funded by the Federal Agency for Jump Innovations (SPRIND) from the funds of the Federal Ministry of Education and Research.
The drug candidate PRI-002 targets small soluble protein aggregates - the so-called amyloid-beta oligomers - which are considered important drivers of the disease process in Alzheimer's. PRI-002 is capable of directly dissolving these toxic amyloid aggregates into their harmless building blocks ('monomers') without the involvement of the immune system, thereby rendering them harmless. "It is, therefore, a purely physical mechanism of action," explains Dieter Willbold. "This sets PRI-002 apart fundamentally from drug candidates based on antibodies, which are currently seeking drug approval."
Great hopes are pinned on the now-approved Phase II study, as Germany alone has approximately 1.1 million Alzheimer's patients for whom, to date, no effective, disease-modifying, and safe medications have been approved.
The results of this study are expected in 2026. The aim is to seamlessly transition into a corresponding Phase III approval study thereafter.
Other news from the department research and development
Biofrontera transfers clinical research to the U.S.
"We can be much more flexible in our strategy to expand our market presence in Europe thanks to the newly defined cost structure"
BASF to research on alternatives to animal testing on behalf of the European Chemicals Agency
Number of animal experiments required for safety assessments of chemical substances to be further reduced
Evotec and Owkin enter an A.I.-powered strategic partnership to accelerate therapeutics pipeline in oncology and I&I
A milestone on the pathway to Lab 4.0: A new standard for the smart lab
SPECTARIS presents the first industrial communication standard for laboratory and analytical devices
Using artificial intelligence to discover therapeutic antibodies
Former EMBL staff scientist founds a start-up – DenovAI – for broader, faster and cheaper antibody discovery using advanced machine learning and computational biophysics
Eppendorf and Neste forge strategic partnership to develop new line of renewable lab plastics
A sustainable choice for labs
UK approves world's first therapy with gene scissors
Developers of the Crispr method were awarded the Nobel Prize in 2020: a drug using the gene scissors has now been approved for the first time
Novel protein to prevent immune system attacks on own body
1.2 million euros for immunology start-up
Startup HyPhoX develops miniaturized biosensors with support from BAM
"The innovative thing about our sensor is that we combine optical, electrical and biochemical analytics on one chip, and we do it in a handy, portable device"
Collaboration to develop vaccine against Helicobacter pylori
Core Facility Animal Models and start-up company Iguana cooperate
Fraunhofer IPA transfers rights to use laboratory robot KEVIN United Robotics Group
KEVIN can be flexibly and intuitively integrated into laboratory infrastructures and automates processes
Dresden-based start-up "DermaPurge" develops skin cleanser for hazardous substances
Global Handwashing Day
SAS accelerates delivery of novel medicines using AI and analytics
Cooperation with AstraZeneca for more innovation in clinical research
New incubator to promote drug discovery and create new therapeutics companies in Singapore
Evotec, ClavystBio, Leaps by Bayer, Lightstone Ventures and Polaris Partners launch "65LAB"
Groundbreaking: Takeda builds lab of the future in Vienna
New research and development laboratory in Vienna's Donaustadt district
New muscle therapy gets fast-track boost
Berlin start-up could soon be helping children with previously incurable muscle diseases thanks to an accelerated approval process
‘Human Inks’ for 3D Printing of Human Tissues
Animal Free 3D Bioprintin: HU3DINKS Project Brings Together Expert Companies
Most read news
The secret of whales: How giant whales defy cancer
Study of gigantism in whales provides clues to genomic mechanism involved in tumor suppression
mRNA therapeutic successfully combats ovarian cancer
The mRNA therapeutic successfully combated cancerous cells and tumors in vitro as well as metastases in mice
Microbe of the Year 2023: Bacillus subtilis – for health and technology
Already, Bacillus subtilis is indispensable in many industries, and many more innovations are expected
Making Ends Meet: Researchers Find That a Protein Superglue is Crucial for DNA Damage Repair
New Understanding for Cancer Treatments
A standard blood test can predict a heart attack
Using the results of a standard blood test and an online tool, you can find out if you are at increased risk of having a heart attack within six months
Learning from Nature: How a fungus makes a hard job easier
Researchers analyze a fungal biosynthetic pathway and discover a capable enzyme
Innovative microscopy technique reveals secrets of lipid synthesis inside cells
Two-color infrared photothermal microscopy (2C-IPM) opens new avenues for long-term study of lipid metabolism in living cells
Artificial cartilage with the help of 3D printing
New approach to producing artificial tissue works with cells in microstructures from the 3D printer
Destroying Tumor Cells with Calcium
Activating calcium channels leads to a deadly influx of calcium ions into tumor cells
Pregnant women should avoid ultraprocessed, fast foods
Curiously, it’s not the food that the study targets but what touches the food before you eat it
More news from our other portals
Planned EU legislation on packaging threatens popular seasonal confectionery
Federal Association of the German Confectionery Industry fears the end of chocolate Easter bunnies & Co.
Mystery of Novel Clove-Like Off-Flavor in Orange Juice Solved
Tracking down off-flavours using techniques such as gas chromatography-olfactometry and aroma extract dilution analysis
Green steel from toxic red mud
An economical process with green hydrogen can be used to extract CO2-free iron from the red mud generated in aluminium production
BASF and Envision Energy enter a collaboration to drive sustainable energy solutions
Collaboration to accelerate conversion of green hydrogen and CO2 to e-methanol
Chemists are on the hunt for the other 99 percent
New mass spectrometry combo offers promise for tapping nature’s unknown chemical universe
Eckes-Granini further expands important out-of-home business segment
Market share gains and double-digit sales growth in 2023
Battery start-up is developing safe, long-lasting thin-film solid-state batteries that can be charged and discharged in one minute
BTRY raises CHF 900,000 in pre-seed funding for the development of an innovative solid-state battery
Microgreens made to order
Italian scientists have tailored iodine and potassium content of radishes, peas, rocket and chard
GPT-3 for chemical research
Researchers develop fast and user-friendly language model for chemical tasks
Revolutionizing batteries: Coffee grounds power high-performance sodium-ion anodes
Using coffee waste as a precursor material for hard carbon synthesis
Greetings from the island of enhanced stability: The quest for the limit of the periodic table
A fresh view on new superheavy elements
Celebrate carnival and do good with gin: Lost Sisters Limited Dry Gin
Lost Sisters Edition aims to generate 11,110 euros in donations with gin de cologne during the carnival season
Detect 'forever chemicals' in under 3 minutes
New lab-based method to detect traces of PFAS from food packaging material, water and soil samples
Ferrero Group continues its growth trajectory
The Group expanded its presence in North America with the strategic acquisition of ice cream maker Wells Enterprises Inc.
Silicon Nitride: Possible Alternative to Lithium Metal Anode?
Research Project: Silicon Nitride-based Particles as Promising Anode Material for Solid State Batteries
Something is happening in the life science industry ...
This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.